• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Emergency Contraception in Slovakia

  • ID: 1268994
  • May 2012
  • Region: Slovakia
  • 20 pages
  • Euromonitor International

Emergency contraception grew by 9% in current value terms to reach sales of EUR60,000 in 2011. Escapelle was the only product present at the end of the review period, as it is intended only for exceptional and urgent cases and should not be used as a regular method of contraception. An overall decrease in value growth was evident each year as a result of changing lifestyles of females. In general emergency contraception is considered a last resort for many women as such medication has the...

The Emergency Contraception in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Emergency Contraception market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

EMERGENCY CONTRACEPTION IN SLOVAKIA
Euromonitor International
May 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2006-2011
Table 2 Sales of Emergency Contraception: % Value Growth 2006-2011
Table 3 Emergency Contraception Company Shares by Value 2007-2011
Table 4 Emergency Contraception Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Emergency Contraception: Value 2011-2016
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016
Executive Summary
Consumer Health in Slovakia Grows in 2011 Despite Poor Economic Situation
Legislative Change Redefines the Slovak Public Healthcare System
Competition Intensifies As Slovakia Adopts New Rules
Chemists/pharmacies Retains Leading Position in 2011
Constant Growth for Consumer Health Over Forecast Period Is Imminent But Will Face Many Constraints
Key Trends and Developments
OTC Sales Grow in Spite of Unfavourable Economic Conditions
All Major Players Strengthen Their Positions in 2011
Private Label and Availability of Consumer Health in Grocery Retailers Remain Limited
Interest Towards Self-medication and Prevention Is on the Rise
Legislative Changes Dramatically Change Healthcare in Slovakia
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC - Switches 2011 (from OTC to Rx)
Definitions
Sources
Summary 2 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Johnson & Johnson Services, Inc. Procter & Gamble Co. Sanofi S.A. GlaxoSmithKline PLC Novartis AG Pfizer, Inc. Boehringer Ingelheim GmbH